Syringolin and glidobactin analogs as proteasome inhibitors for the treatment of cancer
申请人:The Regents of the University of California
公开号:EP2861565B1
公开(公告)日:2016-12-21
SUBSTITUTED MACROCYCLIC COMPOUNDS HAVING PROTEASOME INHIBITORY ACTIVITY
申请人:THE GEGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US20150141392A1
公开(公告)日:2015-05-21
The disclosure provides for novel compounds which have proteasome inhibitory activity, pharmaceutical compositions made thereof, and methods of use thereof to treat various disorders, including cancer and nonmalignant tumors.